Czech medtech startup HTG Medical has raised €450,000 from angel and VC backers, and its proprietary device, the HTG Urogram, has successfully cleared the EU's Medical Device Regulation (MDR) certification, thereby greenlighting its immediate rollout across European and global markets.
The story of HTG Medical began in 2019 at a medtech hackathon hosted by IKEM, where the founders were challenged to digitise urine output tracking. While they narrowly missed first place, the vision and drive to scale the Urogram into a market-ready product remained. Every hour, a nurse in an ICU must physically walk to a patient's bedside, read their urine output from a drainage bag, and manually log the amount. This decades-old, mundane, and time-consuming routine is about to change thanks to HTG Medical. “
"Getting a prototype into the ICU with real patients is one thing. Transitioning it into a certified medical device means perfecting countless details hidden beneath the surface—from measurement accuracy and engineering reliability to secure hospital data integration, a robust quality management system, and an airtight development and testing lifecycle,” says Max Klimeš, CTO and co-founder.
The HTG Urogram tracks fluid output completely automatically, displaying real-time metrics on an integrated screen and transmitting them directly to Hospital Information Systems (HIS). This returns up to one hour of valuable time back to nurses every day, allowing them to focus on direct patient care rather than paperwork. Furthermore, automation eliminates human error; according to external research, the error rate of manual logging and fluid tracking in ICUs can skyrocket up to 26 per cent.
